Treatment of primary hepatic neuroendocrine tumors
10.3760/cma.j.issn.1007-631X.2014.07.017
- VernacularTitle:原发性肝脏神经内分泌癌的治疗研究
- Author:
Yuanbiao ZHANG
;
Changku JIA
;
Ke SUN
;
Defei HONG
- Publication Type:Journal Article
- Keywords:
Carcinomar,hapatocellular;
Neuroendocrine tumors;
Antineopastic protocols
- From:
Chinese Journal of General Surgery
2014;29(7):542-544
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the treatment of primary hepatic neuroendocrine tumors (PHNET).Methods The therapeutic treatments of 9 PHNET patients from January 2003 to January 2010 in 3 hospitals were retrospective analyzed and followed up.Results Diagnosis of PHNET was confirmed immunohistochemically and by excluding extrahepatic primary sites.The survival is significantly dependent on tumor resectability.One patient received only radiotherapy and one with only chemotherapy,one with radiofrequency ablation.Six patients received R0 resection,one received postoperative radiotherapy,one with TACE perioperatively and internal radiotherapy.Two patients were lost to follow up 3 patients died and 4 were alive.Intrahepatic recurrence was found in 1 patient and metastasis to bone in 2 patients.Survival time ranged from 11 days to 66 months.Conclusions PHNET is an extremely rare entity with difficulty in early diagnosis.Curative liver resection integrated with transarterial chemoembolization or radiotherapy is considered to be an effective modality.
